Public Law 112-144, Title XI, Subtitle D
GPTKB entity
Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law_subtitle
|
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:citation |
gptkb:126_Stat._993
|
| gptkbp:contains |
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
| gptkbp:dateEnacted |
July 9, 2012
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:establishes |
gptkb:GAIN_Act
|
| gptkbp:fullTitle |
gptkb:Generating_Antibiotic_Incentives_Now_(GAIN)_Act
|
| gptkbp:partOf |
gptkb:Public_Law_112-144
|
| gptkbp:provides |
Incentives for development of qualified infectious disease products
Extended exclusivity for certain antibiotics |
| gptkbp:purpose |
To encourage development of new antibiotics
|
| gptkbp:subject |
Antibiotic resistance
Antibiotic drug development |
| gptkbp:bfsParent |
gptkb:Synthetic_Drug_Abuse_Prevention_Act_of_2012
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Public Law 112-144, Title XI, Subtitle D
|